Gastrointestinal stromal tumor other diagnostic studies: Difference between revisions
Akshun Kalia (talk | contribs) |
Akshun Kalia (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}};{{AE}} | {{CMG}};{{AE}} | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Endoscopic guided biopsy may be done for definite diagnosis of gastrointestinal stromal tumor. However, percutaneous biopsy is not routinely recommended. | Endoscopic guided biopsy may be done for definite diagnosis of gastrointestinal stromal tumor. However, percutaneous biopsy is not routinely recommended. | ||
*Patients with unresectable GIST must undergo biopsy to determine tumor cell type and chemotherapy. | |||
*GISTs are highly vascular which puts them at a risk of bleeding. | *GISTs are highly vascular which puts them at a risk of bleeding. | ||
*Percutaneous fine needle biopsy may put the patient at an increased risk of tumor rupture and bleeding. | **Percutaneous fine needle biopsy may put the patient at an increased risk of tumor rupture and bleeding. | ||
*Percutaneous biopsy can also lead to tumor seeding along the biopsy tract such as peritoneum or mesentery. | **Percutaneous biopsy can also lead to tumor seeding along the biopsy tract such as peritoneum or mesentery. | ||
*Thus, patients in whom surgery is an option are advised not to undergo biopsy. | **Thus, patients in whom surgery is an option are advised not to undergo biopsy. | ||
==References== | ==References== |
Revision as of 01:39, 18 December 2017
Gastrointestinal stromal tumor Microchapters |
Differentiating Gastrointestinal stromal tumor from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Gastrointestinal stromal tumor other diagnostic studies On the Web |
American Roentgen Ray Society Images of Gastrointestinal stromal tumor other diagnostic studies |
FDA on Gastrointestinal stromal tumor other diagnostic studies |
CDC on Gastrointestinal stromal tumor other diagnostic studies |
Gastrointestinal stromal tumor other diagnostic studies in the news |
Blogs on Gastrointestinal stromal tumor other diagnostic studies |
Directions to Hospitals Treating Gastrointestinal stromal tumor |
Risk calculators and risk factors for Gastrointestinal stromal tumor other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief:
Other Diagnostic Studies
Endoscopic guided biopsy may be done for definite diagnosis of gastrointestinal stromal tumor. However, percutaneous biopsy is not routinely recommended.
- Patients with unresectable GIST must undergo biopsy to determine tumor cell type and chemotherapy.
- GISTs are highly vascular which puts them at a risk of bleeding.
- Percutaneous fine needle biopsy may put the patient at an increased risk of tumor rupture and bleeding.
- Percutaneous biopsy can also lead to tumor seeding along the biopsy tract such as peritoneum or mesentery.
- Thus, patients in whom surgery is an option are advised not to undergo biopsy.